GNOM Holdings — Global X Genomics & Biotechnology ETF
All 51 reported holdings of Global X Genomics & Biotechnology ETF (GNOM) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Guardant Health, Inc. | 5.59% | $3.12M |
| Illumina, Inc. | 4.82% | $2.69M |
| Natera, Inc. | 4.15% | $2.32M |
| Biomarin Pharmaceutical Inc. | 4.09% | $2.28M |
| Arrowhead Pharmaceuticals, Inc. | 4.07% | $2.27M |
| Legend Biotech Corp | 4.05% | $2.26M |
| Praxis Precision Medicines Inc | 4.01% | $2.24M |
| Twist Bioscience Corp | 3.97% | $2.21M |
| Vertex Pharmaceuticals Incorporated | 3.95% | $2.20M |
| CRISPR Therapeutics AG | 3.85% | $2.15M |
| Veracyte Inc | 3.64% | $2.03M |
| Qiagen N.V. | 3.54% | $1.97M |
| BioNTech SE | 3.41% | $1.90M |
| Bio-Techne Corporation | 3.41% | $1.90M |
| Moderna, Inc. | 3.28% | $1.83M |
| 10X Genomics Inc | 3.23% | $1.80M |
| Beam Therapeutics Inc | 3.09% | $1.72M |
| Bnyrepos | 3.05% | $1.70M |
| Eli Lilly And Company | 2.32% | $1.29M |
| Ultragenyx Pharmaceutical Inc | 2.25% | $1.26M |
| Caris Life Sciences, Inc. | 2.03% | $1.13M |
| Genscript Biotech Corp | 2.00% | $1.12M |
| BillionToOne Inc | 1.97% | $1.10M |
| Gilead Sciences, Inc. | 1.95% | $1.09M |
| Astrazeneca PLC | 1.83% | $1.02M |
| Sarepta Therapeutics, Inc. | 1.80% | $1.00M |
| Uniqure NV | 1.59% | $889.79K |
| Intellia Therapeutics, Inc. | 1.59% | $888.30K |
| Stoke Therapeutics Inc | 1.45% | $810.83K |
| GeneDx Holdings Corp | 1.35% | $752.92K |
| Danaher Corporation | 1.17% | $652.68K |
| Bristol-Myers Squibb Company | 1.16% | $644.59K |
| Vir Biotechnology Inc | 1.11% | $619.15K |
| Caredx, Inc. | 1.05% | $587.27K |
| WAVE Life Sciences Ltd | 1.03% | $574.16K |
| Personalis Inc | 0.79% | $438.62K |
| Maravai LifeSciences Holdings Inc | 0.51% | $282.29K |
| Bruker Corporation | 0.43% | $238.86K |
| Pacific Biosciences Of California, Inc. | 0.40% | $225.64K |
| Benitec Biopharma Inc | 0.38% | $212.13K |
| Agilent Technologies, Inc. | 0.38% | $210.48K |
| Fulgent Genetics, Inc. | 0.36% | $200.08K |
| Standard Biotools Inc. | 0.35% | $196.40K |
| Myriad Genetics, Inc. | 0.35% | $194.38K |
| Editas Medicine, Inc. | 0.34% | $189.35K |
| Prime Medicine, Inc | 0.34% | $188.54K |
| Regenxbio Inc | 0.33% | $181.47K |
| Rocket Pharmaceuticals, Inc. | 0.32% | $176.86K |
| Mesa Laboratories, Inc. | 0.29% | $162.11K |
| Caribou Biosciences Inc | 0.29% | $160.91K |
| Quest Diagnostics Incorporated | 0.28% | $153.78K |
GNOM overview: performance, fees, allocation and SEC filings